8 Results for "

Nocturia

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Nocturia" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-14887
CAS No.: 347887-36-9
Purity:  99.43%
Synonyms: VA106483
Target:  

Vasopressin Receptor

Research Areas:  

Metabolic Disease

Fedovapagon (VA106483) is a selective and orally active vasopressin V2 receptor (V2R) agonist with an EC50 of 24 nM. Fedovapagon can be used in the research of nocturia .
loading...
    loading...
Cat. No.: HY-W095705A
CAS No.: 6487-38-3
Research Areas:  

Endocrinology

3-Hydroxypropionic acid sodium is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid sodium exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid sodium can be used in studies related to nocturia .
loading...
    loading...
Cat. No.: HY-W101935
CAS No.: 113712-06-4
Synonyms: N-Boc-D-arginine hydrochloride
Research Areas:  

Others

N-Boc-D-Arg hydrochloride (N-Boc-D-arginine hydrochloride) is an amino acid derivative with a Boc protecting group, which can be used to synthesize desmopressin with the effects of improving nocturia, urinary incontinence and enuresis .
loading...
    loading...
Cat. No.: HY-W095705
CAS No.: 503-66-2
Research Areas:  

Endocrinology

3-Hydroxypropionic acid (30% in water) is a metabolite of β-Alanine (HY-N0230) and also a precursor for the synthesis of various chemical products. 3-Hydroxypropionic acid (30% in water) exhibits reduced urinary levels in elderly male patients with nocturia, which correlates with altered β-Alanine metabolic pathogenesis. 3-Hydroxypropionic acid (30% in water) can be used in studies related to nocturia .
loading...
    loading...
Cat. No.: HY-116567A
CAS No.: 192514-57-1
Purity:  99.94%
Target:  

Endogenous Metabolite

Research Areas:  

Endocrinology

(S)-OPC-51803 is an agonist of the vasopressin V2 receptor, with activity in suppressing nocturia and urinary incontinence. (S)-OPC-51803 was evaluated in terms of biological activity and showed a stronger V2 receptor agonist effect compared to its (R)-isomer. The use of (S)-OPC-51803 may improve the patient's ability to control nocturnal polyuria .
loading...
    loading...
Cat. No.: HY-W039283
CAS No.: 345-24-4
Target:  

MCHR1 (GPR24)

Research Areas:  

Neurological Disease Cancer

MCH-1 antagonist 2 (l-BROMO-2,4-DIFLUORO-5-NITROBEN-ZENE) is a melanin concentrating hormone-1 (MCH1) receptor-selective 4-aryl piperidine. MCH-1 antagonist 2 can be used for the research of depression, anxiety, obesity, urge incontinence, urinary incontinence, major depression, bipolar disorder, agoraphobia, specific phobia, social phobia, obsessive-compulsive disorder, post-traumatic stress disorder, acute stress disorder, urinary frequency, urinary urgency, nocturia, enuresis, bulimia, bulimia nervosa, anorexia nervosa, major depressive disorder, dysthymic disorder, bipolar 1 and 2 disorders, schizoaffective disorder, cognitive disorders with depressed mood, personality disorders, insomnia, hypersomnia, narcolepsy, circadian rhythm sleep disorder, nightmare disorder, sleep terror disorder, sleepwalking disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, overactive bladder .
loading...
    loading...
Cat. No.: HY-109181
CAS No.: 2379889-71-9
Synonyms: SK-1404; KRP-N118
Target:  

Vasopressin Receptor

Research Areas:  

Others

Lazuvapagon (SK-1404) is a vasopressin V2 receptor agonist for the research of nocturia .
loading...
    loading...
Cat. No.: HY-186040
CAS No.: 790694-26-7
Target:  

Vasopressin Receptor

Research Areas:  

Neurological Disease

ASP-7035 (compound 55) is an arginine vasopressin V2 receptor agonist. ASP-7035 can be used in the research of nocturia .
loading...
    loading...